Bill Grambley, CEO of AllazoHealth, delves into the potential of AI to revolutionize patient engagement and adherence.
Miranda Schmalfuhs
Advertisement
Miranda Schmalfuhs is the associate group social media editor of Pharmaceutical Executive, Pharmaceutical Commerce, and Applied Clinical Trials and can be reached at mschmalfuhs@mjhlifesciences.com.
Articles by Miranda Schmalfuhs
In this Pharmaceutical Executive video interview, Edoardo Madussi, Head of Business Development, Intelligencia AI identifies the risks associated with relying heavily on open-access AI models in terms of data security, intellectual property, and more.
In this part of his Pharmaceutical Executive video interview, Ian Baer, Founder & CEO of Sooth, explores the contributing factors growing distrust and uncertainty surrounding social media.
The latest news for pharma industry insiders.
The latest news for pharma industry insiders.
In this Pharmaceutical Executive video interview, Edoardo Madussi, Head of Business Development, Intelligencia AI discusses where else the the pharmaceutical value chain may be impacted by LLMs.
The latest news for pharma industry insiders.
In this Pharmaceutical Executive video interview, Edoardo Madussi, Head of Business Development, Intelligencia AI identifies potential disruptions AI-driven models could have to the current R&D practices in the industry.
In this Pharmaceutical Executive video interview, Edoardo Madussi, Head of Business Development, Intelligencia AI compares and discusses the potential impact of AI-driven drug discovery platforms.
The latest news for pharma industry insiders.
The latest news for pharma industry insiders.
Dr. Shakthi Kumar, EDETEK, Inc.'s Chief Strategy and Business Officer, discusses future plans for R&D Cloud.
The latest news for pharma industry insiders.
The latest news for pharma industry insiders.
Dr. Shakthi Kumar, EDETEK, Inc.'s Chief Strategy and Business Officer, explores the company's launch of R&D Cloud.
The two organizations will provide multi-modal learning experiences, opportunities to work with peers, and more.
The latest news for pharma industry insiders.
Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), discusses how to combat the spread of misinformation on social media, opportunities that social media presents, advancements in fertility technology, and more.
The new Medicare alternative payment model aims to improve dementia care coordination.
The latest news for pharma industry insiders.
The latest news for pharma industry insiders.
The government agency says X no longer suits its communication needs.
Campaign encourages the use of low-dose aspirin to help reduce the risk of preeclampsia and the complications that come with it.
The latest news for pharma industry insiders.
The latest news for pharma industry insiders.
New partnership hopes to give BSS patients more options for treatment.
The latest news for pharma industry insiders.
Expanded GTM services aim to ensure members receive tests at the optimal times while cutting down on testing misuse.
The latest news for pharma industry insiders.
The latest news for pharma industry insiders.
Advertisement
